CSE's Barrington Miller is joined by Iris Bincovich, CEO of InnoCan Pharma (CSE:INNO) to discuss the company's focus as a specialty pharmaceutical company including the development of products that harness the unique properties of Cannabinoids combined with smart delivery formulations. The conversation also highlights the importance - and impact - that achieving milestones has had on the company's life as a public company.
Here's an overview of what Barrington and Iris discuss in this edition of the "Exchange for Entrepreneurs" podcast:
0:00 - Re-introducing Iris Bincovich and Innocan Pharma
3:31 - Iris' background in chemistry and the healthcare industry
5:22 - Exporting Israeli innovation across the globe
8:41 - Going public in Canada and the importance of meeting milestones
13:47 - Opportunities for growth in 2022
16:19 - Accessing Innocan's products
18:35 - Iris' favourite restaurant
Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
STAY CONNECTED WITH THE CSE
=============================
- PODCAST: https://blog.thecse.com/cse-podcasts/
- INSTAGRAM: https://www.instagram.com/canadianexchange/
- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
- TWITTER: https://twitter.com/CSE_News
- BLOG: https://blog.thecse.com/
- WEBSITE: https://thecse.com/
- MAGAZINE: https://issuu.com/thecse/docs
The CSE Podcast
